Association between serum ligands and the skin toxicity of anti‐epidermal growth factor receptor antibody in metastatic colorectal cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1349-7006|106|5|604-610

ISSN： 1347-9032

Source： Cancer Science, Vol.106, Iss.5, 2015-05, pp. : 604-610

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DNA methylation status as a biomarker of anti‐epidermal growth factor receptor treatment for metastatic colorectal cancer

By  

Cancer Science, Vol. 106, Iss. 12, 2015-12 ,pp. : 1722-1729

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I study of weekly nab‐paclitaxel combined with S‐1 in patients with human epidermal growth factor receptor type 2‐negative metastatic breast cancer

By  

Cancer Science, Vol. 106, Iss. 6, 2015-06 ,pp. : 734-739

John Wiley & Sons Inc

Access to resources Recommend Favorite

Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy

By  

Cancer Science, Vol. 107, Iss. 9, 2016-09 ,pp. : 1179-1186

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epidermal growth factor receptor and AKT1 gene copy numbers by multi‐gene fluorescence in situ hybridization impact on prognosis in breast cancer

By  

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 642-649

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transfection efficiency of depolymerized chitosan and epidermal growth factor conjugated to chitosan–DNA polyplexes

By Supaprutsakul Sasamon   Chotigeat Wilaiwan   Wanichpakorn Supreya   Kedjarune-Leggat Ureporn  

Journal of Materials Science: Materials in Medicine, Vol. 21, Iss. 5, 2010-05 ,pp. : 1553-1561

Springer Publishing Company

Access to resources Recommend Favorite